Subvolts take AI meets biology: Daphne Koller explains how machine learning transforms drug development. Aug 25, 2020 - Developers
- Learn how AI is being used in complex scientific research beyond typical software applications.
- Business
- Understand how AI and machine learning are transforming industries like pharmaceuticals and healthcare.
This is a solid interview with a leader in applying AI to a critical scientific field.
Daphne Koller, PhD: CEO and founder of insitro
Audio streams from Microsoft. Your place is remembered on this device.
From Subvolts
Summary and analysis by Subvolts editorial, AI-assisted.
This episode features Daphne Koller, CEO and founder of insitro, discussing her work at the intersection of machine learning and biology. Koller, a former Stanford professor, is transforming pharmaceutical drug development through digital biology, a field impacting health, agriculture, and biomaterials. The conversation explores her innovative approaches.
Daphne Koller uses computers to help discover new medicines faster. Her company, insitro, combines AI with biology to understand diseases and create better treatments. This work could lead to new ways to improve human health.
This episode offers insight into how AI is being applied to solve complex biological problems. Listeners will learn about the emerging field of digital biology and its potential to revolutionize drug discovery and other areas. It is for anyone interested in the practical applications of AI in science and medicine. This connects to frontier labs' increasing focus on AI for scientific research and drug development.
- HostKevin Scott
- GuestDaphne KollerCEO and founder, insitro
- Guest: Daphne Koller, PhD
- Title: CEO and founder of insitro
- Show: Behind The Tech with Kevin Scott
- Length: 61 minutes
- Guest Background: Former Stanford University professor, MacArthur Fellow, TIME 100 most influential people
Former Stanford University professor Daphne Koller's cutting edge work combines machine learning and biology to transform pharmaceutical drug development. Her work at insitro is part of an emerging field - digital biology - that is having an impact on multiple fields, including biomaterial design, agriculture, and human health. This MacArthur Fellow was also named one of TIME Magazine's 100 most influential people.
Click here for transcript of this episode.
- digital biology
- Daphne Koller
- using computers and data to understand and improve biological processes.
1 h 0634 minYear in Review 2024
WithXyla Foxlin, Lisa Su, Ben Laude, Ethan Mollick
Questions people ask
- What is Daphne Koller's background?
- Daphne Koller is a former Stanford University professor and a MacArthur Fellow.
- What is insitro's focus?
- Insitro combines machine learning and biology to transform pharmaceutical drug development.
Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to Microsoft.